Oxalys Pharmaceuticals
oxalys.caOxalys is developing disease-modifying therapeutics for neurodegenerative disorders, including Huntington’s, Parkinson’s, and Alzheimer’s diseases. The company’s therapeutic pipeline is derived from its proprietary drug discovery platform that involves high-content screening of transgenic primary neurons. The company takes a global collaborative approach to product development. The Oxalys lead therapeutic, OXD4, is being developed as a treatment of Huntington’s disease.
Something looks off?Open jobs at Oxalys Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.